GlassScriptPhysician profile
Alison L Hoffman
NPI 1598025702
$3,683.12
in general payments reported to CMS, 2019-2025
45 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $502 · 2022: $545 · 2023: $828 · 2024: $799 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,635.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $716.63 | 2021-2025 | |
| Janssen Biotech, INC. | $603.15 | 2021-2025 | Rybrevant, Carvykti, Erleada |
| Stemline Therapeutics INC. | $263.55 | 2023-2025 | Orserdu |
| Adaptive Biotechnologies Corporation | $185.85 | 2022-2023 | Clonoseq |
| Incyte Corporation | $174.96 | 2024-2025 | Monjuvi, Pemazyre, Jakafi |
| Abbvie INC. | $149.34 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $101.77 | 2021-2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $97.51 | 2021-2025 | |
| Glaxosmithkline, LLC. | $90.69 | 2023-2025 | Zejula, Jemperli |
| Regeneron Healthcare Solutions, INC. | $85.99 | 2021-2023 | Libtayo |
| Genzyme Corporation | $82.74 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.26 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $80.00 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Gilead Sciences, INC. | $64.20 | 2022-2024 | |
| Amgen INC. | $57.55 | 2022-2023 | Vectibix, Nplate, Xgeva |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.